Editorial
 LANDMARK DECISION ON ASR   
 Monday, December 10, 2018 
 In a landmark decision, the Union Health Ministry on November 29 this year approved a formula for determination of compensation for patients who had received faulty Articular Surface Replacement (ASR) hip implants manufactured by DePuy International Ltd, UK, a subsidiary of Johnson & Johnson (J&J). 
  Past Editorial...  
TODAY'S NEWS
13:00  [IST]Sandoz, Pear Therapeutics get US FDA approval for reSET-O to treat opioid use disorder
12:00  [IST]Researchers find frequent red meat consumption to high levels of chemical associated with heart disease
11:00  [IST]Amgen, Lazarex Cancer Foundation join hand to support more access to clinical trials for cancer patients in US
10:00  [IST]BC Platforms partners with Medaffcon to streamline collaboration between biobanks & researchers
09:00  [IST]Daiichi Sankyo partners with Sarah Cannon to develop novel cancer therapies
more news >>
TOP NEWS
08:00  [IST]Five-year Indo-US funding programme to help boost tuberculosis research; DBT, NIH to pool resources
08:00  [IST]MADC appoints agency to come out with DPR on developing medical device park at MIHAN, Nagpur
08:00  [IST]Tamil Nadu DC constitutes three special squads to investigate cases of cross border sale of nitrazepam to Kerala
08:00  [IST]Karnataka commences DNB courses at 9 govt hospitals to offset shortage of specialist doctors
08:00  [IST]Indus Health Plus plans to invest Rs.75 crore to expand personal genetic test to 5 lakh people
08:00  [IST]WHO backing helps manufacturers from developing countries thwart MNC bid to alter ISO definition for AD syringes
more news >>
YESTERDAY'S NEWS
18:00  [IST]Vanda reports positive study results for Hetlioz in patients with SMS
17:25  [IST]Ambuja Cement’s multispeciality hospital receives NABH’s pre-accreditation
17:00  [IST]Roche appoints William (Bill) Anderson as CEO from January 01, 2019
16:00  [IST]Mundipharma to market pain drug, Norspan in Japan
15:00  [IST]Biohaven Announces Positive Results from Ongoing Rimegepant Long-Term Safety Study
14:50  [IST]Antardhwani & WHO along with Karnataka farmers mull on an alternative for tobacco cultivation to keep H&N cancers at bay
more news >>
INTERVIEW  
Rising burden of NCDs impacts Indian healthcare scene
Gagan Singh Bedi, managing director, AstraZeneca Pharma India Gagan-Singh-Bedi.jpg
Past Interviews...
 
  What's New?  
 
Opinion Poll
 
 
Will the central govt's decision to replace MCI with National Medical Commission boost the medical education scenario in the country?
  
 
 
   
 
  Corporate
Pharma Stocks
Executive Diary
Pharma People
Product Launches
  Special Features
Features
  Chronicle Pharmabiz Specials
Forthcoming
  Past
 
  Forthcoming Events
International
  Domestic
 
TENDERS & PROJECTS
Tenders & Enquiries
Pharma Projects
CORPORATE
Company Profile
Corporate Results
Corporate X-ray
Pharmabiz Studies of Top Companies
US FDA UPDATE
US FDA: ANDA
US FDA: Warnings
US FDA: Approved NMEs
US FDA: New Approvals
EXPORT & IMPORT
Drug Export Procedures
Drug Units With WHO GMP Certification
Pharma Export Data
Import Reg. Update
PHARMA LAWS & DOCUMENTS
Notifications
Pharma Regulations
Patent Laws and Amendments
Patent Scan
Documents
New Drug Approvals
Notified Prices
LIST OF LABS & GOVT. BODIES
Govt Recognised In-House R&D Units
AICTE Boards & Committees
List of Indian CROs
List of CROs (International)
Govt & approved labs of India
List of State Drugs Controllers
 
 
ipc_2018
BTS_2018
cphi-india_Banner-150x60
 
 
 
 
Copyright © 2016 Saffron Media Pvt. Ltd |